CILOSTAZOL
NDC 84386-003, CILOSTAZOL, tablet, from Aurobindo Pharma Limited.
- Product NDC
- 84386-003
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077019
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/84386-003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CILOSTAZOL100 mg/1
Pharmacologic classes
Phosphodiesterase 3 Inhibitor [EPC]; Phosphodiesterase 3 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 84386-003-60 | 84386000360 | 60 TABLET in 1 BOTTLE (84386-003-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/7c841eed-a98f-43c3-baaf-bf5502207a69
Use it
Look up 84386-003 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/84386-003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 84386-003. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.